Roswell Park Cancer Institute
Clinical trials sponsored by Roswell Park Cancer Institute, explained in plain language.
-
Lung cancer pilot: High-Dose radiation before surgery tested
Disease control TerminatedThis early-phase pilot study looked at combining stereotactic body radiation therapy (SBRT) with surgery for patients with stage I-IIIA non-small cell lung cancer. SBRT delivers very high, precise radiation doses to the tumor while sparing healthy tissue. The study aimed to check…
Phase: EARLY_PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Experimental melanoma combo trial shutters after just one patient
Disease control TerminatedThis phase II trial tested a mix of a personalized dendritic cell vaccine and three immune-boosting drugs in people with advanced melanoma that no longer responded to PD-1/PD-L1 checkpoint inhibitors. The goal was to see if the combination could shrink tumors or slow their growth…
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Light therapy boosts immune attack on lung cancer? early trial halted
Disease control TerminatedThis early-phase trial tested whether a light-activated drug (photodynamic therapy) could help immunotherapy work better in patients with non-small cell lung cancer that has spread to the lining of the lung or with mesothelioma. Only 5 people took part, and the study was stopped …
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Cancer Patients' COVID-19 trial halted after just 4 volunteers
Disease control TerminatedThis early-phase study aimed to see if combining two immune-stimulating drugs (rintatolimod and interferon alpha-2b) could help cancer patients fight off COVID-19. Only 4 people took part before the study was stopped early. The main goals were to check safety and measure how the …
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Can a Two-Drug punch restore sensitivity in Hard-to-Treat prostate cancer?
Disease control TerminatedThis early-phase trial tested whether adding decitabine/cedazuridine to enzalutamide could help men with metastatic castration-resistant prostate cancer whose cancer had stopped responding to enzalutamide alone. Only 8 men were enrolled before the study was terminated. The goal w…
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Virtual reality could help measure and treat cancer pain, study suggests
Knowledge-focused TerminatedThis study explored whether a wearable brain scanner (fNIRS) could objectively measure pain in cancer patients and survivors. It also tested if virtual reality (VR) relaxation could help reduce pain. The study included 106 participants, including healthy volunteers and cancer pat…
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Tobacco flavor study seeks to understand Vapers' sense of smell and taste
Knowledge-focused TerminatedThis study looked at how well people can identify and rate different flavors and smells in e-liquids. Researchers compared the abilities of everyday vapers and trained experts to detect flavors, find the lowest detectable levels, and pick out the main flavor in mixtures. The goal…
Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Vape flavor study reveals how puffing patterns change
Knowledge-focused TerminatedThis study looked at how the flavor and type of nicotine in vape liquids change the way people puff. Researchers measured things like how many puffs people took, how long each puff lasted, and the volume of each puff. The goal was to better understand how these factors might affe…
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC